CAUTION: We have been advised that fraudulent emails with a modified domain name have been sent by a source purporting to be from Aird & Berlis LLP. These communications are not legitimate and are not from Aird & Berlis LLP. Disregard any such emails and do not engage with the sender or the email in any way. Please report the attempted fraud by contacting the Canadian Anti-Fraud Centre and by emailing Aird & Berlis LLP at help@airdberlis.com.

Sean Green

Associate Admitted to the Ontario Bar: 2018

When it comes to complex capital markets transactions, Sean provides clients with the support they need to navigate regulatory requirements and achieve their business goals. He is highly organized in his approach and delivers concise advice that his clients can trust.

As a member of the firm's Capital Markets Group, Sean works with clients across a variety of industries. His practice focuses on securities law, corporate finance, and mergers and acquisitions. Sean also assists clients in meeting ongoing disclosure requirements.

Sean joined Aird & Berlis as an associate after summering and articling with the firm.

Representative Matters

Represented Spectra7 Microsystems Inc., a leading provider of high-performance analog semiconductor products for broadband connectivity markets, in the completion of brokered and non-brokered private placements for gross proceeds of $6.3 million.

Represented Galane Gold Ltd. (TSX-V: GG; OTCQB: GGGOF), a gold producer and explorer with mining operations and exploration tenements in Botswana, South Africa and New Mexico, in connection with its acquisition of the Summit Mine and Banner Mill in New Mexico and a $9.7 million private placement.

Represented Small Pharma Ltd, a U.K.-based neuropharmaceutical company specialized in IP-led development of novel treatments for mental health conditions, in its acquisition by Small Pharma Inc. (formerly Unilock Capital Corp.) (TSXV: DMT) by way of a qualifying transaction and its related brokered and non-brokered private placements for aggregate gross proceeds of $63 million and initial TSX Venture Exchange listing.

Represented Cybin Inc., a biotechnology company focused on progressing psychedelic therapeutics, in the completion of a bought deal short form prospectus offering of units for aggregate gross proceeds of approximately $34 million.

Represented Cybin Inc. (the “Company”) (NEO: CYBN) in the completion of its reverse takeover of Clarmin Explorations Inc. pursuant to the terms of an amalgamation agreement among Cybin Corp., Clarmin and a wholly-owned subsidiary of the Company as well as a private placement offering of 60 million subscription receipts for aggregate gross proceeds of $45 million.

Represented Harborside Inc. (formerly Lineage Grow Company Ltd.) (CSE: HBOR) in the completion of its reverse takeover of FLRish, Inc. pursuant to the terms of a merger agreement among the Company, FLRish and Lineage Merger Sub Inc. by way of a “three-cornered merger.”

Represented Eve & Co Incorporated (TSXV: EVE) in the completion of a $10.45 million special warrant bought deal private placement.

Represented Eve & Co Incorporated (TSXV: EVE) in the completion of an $18.7 million construction facility with Royal Bank of Canada to fund the completion of a 780,000 sq. ft. expansion of its greenhouse production facility.

Selected Publications

"CRA's Super-Priority Remains Operative Over Pre-Bankruptcy Payments to Secured Creditor," co-authored with Alyssa Gebert, Aird & Berlis Financial Services Flash, November 2017.

"NEB Predicts Canadian Fossil Fuel Use Will Peak in 2019," co-authored with David Stevens, Aird & Berlis Energy Insider, November 2017.

"Practically Perfect – Errors in Financing Statements," co-authored with Timothy Jones, Aird & Berlis Financial Services Flash, September 2017.

Education

  • JD, Osgoode Hall Law School, 2017
  • MA, University of Ottawa, 2015
  • BA, University of Ottawa, 2012